Table 4.
Parameters | Baseline, mean (SD) | 3 months, mean (SD) | Change in 0–3 months, mean (SD) | P-value | 6 months, mean (SD) | Change in 0–6 months, mean (SD) | P-value |
---|---|---|---|---|---|---|---|
Vision-related quality of life | |||||||
NEI-VFQ-25 composite | 84.8±14.5 | 87.8±11.9 | 3.04±6.98 | 0.005 | 89.3±11.5 | 3.58±7.11 | 0.002 |
Effect size | 0.23 | 0.34 | |||||
Subscales | |||||||
General health | 62.2±23.6 | 60.6±19.6 | −1.7±17.8 | 0.538 | 58.9±19.3 | −3.3±17.4 | 0.204 |
General vision | 70.2±19.4 | 74.2±17.9 | 4.0±13.9 | 0.060 | 76.0±15.7 | 3.1±14.7 | 0.164 |
Ocular pain | 84.2±16.1 | 86.4±16.0 | 2.2±14.7 | 0.315 | 87.8±14.0 | 3.6±13.5 | 0.079 |
Near activities | 80.6±21.5 | 83.1±19.0 | 2.3±11.9 | 0.151 | 87.5±18.9 | 5.6±10.3 | 0.001 |
Effect size | 0.34 | ||||||
Distance activities | 85.3±18.2 | 88.2±16.1 | 3.0±8.7 | 0.028 | 89.0±16.9 | 3.7±10.0 | 0.017 |
Effect size | 0.17 | 0.28 | |||||
Social functioning | 93.3±915.2 | 95.3±11.7 | 1.9±8.4 | 0.128 | 95.6±11.0 | 1.9±7.5 | 0.090 |
Mental health | 80.0±21.3 | 86.3±12.5 | 6.3±14.7 | 0.006 | 87.1±14.8 | 5.3±11.5 | 0.003 |
Effect size | 0.36 | 0.39 | |||||
Role difficulties | 80.3±22.4 | 84.2±20.5 | 3.9±19.7 | 0.193 | 86.7±19.1 | 5.3±17.0 | 0.043 |
Dependency | 94.6±15.0 | 95.2±11.0 | 0.6±10.7 | 0.730 | 95.9±10.1 | 0.6±9.6 | 0.701 |
Driving | 90.3±17.0 | 92.7±16.0 | 2.3±8.2 | 0.166 | 93.0±16.3 | 3.3±9.0 | 0.076 |
Color vision | 93.3±16.3 | 95.0±12.6 | 1.7±15.4 | 0.473 | 97.2±9.6 | 2.2±14.9 | 0.323 |
Peripheral vision | 85.6±23.5 | 90.6±16.2 | 5.0±16.5 | 0.048 | 90.6±16.2 | 5.0±18.2 | 0.071 |
Effect size | 0.25 | ||||||
Quality of life – overall health score index | |||||||
EQ-5D | 0.89±0.13 | 0.89±0.13 | 0.005±0.083 | 0.706 | 0.92±0.13 | 0.032±0.096 | 0.034 |
Effect size | 0.23 |
Notes: Results are in response to an analysis of variance; significant P-values are those <0.05.
Abbreviation: EQ-5D, EuroQoL-5 dimension.